Brainstorm Cell Therapeutics Inc (BCLI)
1.80
-0.06
(-3.23%)
USD |
NASDAQ |
Nov 04, 16:00
1.78
-0.02
(-1.11%)
After-Hours: 20:00
Brainstorm Cell Therapeutics Max Drawdown (5Y): 99.30% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.30% |
| September 30, 2024 | 99.16% |
| August 31, 2024 | 99.16% |
| July 31, 2024 | 99.16% |
| June 30, 2024 | 99.16% |
| May 31, 2024 | 99.16% |
| April 30, 2024 | 99.16% |
| March 31, 2024 | 99.16% |
| February 29, 2024 | 99.16% |
| January 31, 2024 | 99.16% |
| December 31, 2023 | 99.16% |
| November 30, 2023 | 99.16% |
| October 31, 2023 | 99.16% |
| September 30, 2023 | 98.87% |
| August 31, 2023 | 92.27% |
| July 31, 2023 | 92.27% |
| June 30, 2023 | 92.27% |
| May 31, 2023 | 92.27% |
| April 30, 2023 | 92.27% |
| March 31, 2023 | 92.27% |
| February 28, 2023 | 92.27% |
| January 31, 2023 | 92.27% |
| December 31, 2022 | 92.27% |
| November 30, 2022 | 91.54% |
| October 31, 2022 | 85.62% |
| Date | Value |
|---|---|
| September 30, 2022 | 85.62% |
| August 31, 2022 | 85.62% |
| July 31, 2022 | 85.62% |
| June 30, 2022 | 84.72% |
| May 31, 2022 | 84.72% |
| April 30, 2022 | 84.15% |
| March 31, 2022 | 84.15% |
| February 28, 2022 | 84.15% |
| January 31, 2022 | 84.15% |
| December 31, 2021 | 84.15% |
| November 30, 2021 | 84.15% |
| October 31, 2021 | 83.81% |
| September 30, 2021 | 83.02% |
| August 31, 2021 | 83.02% |
| July 31, 2021 | 83.02% |
| June 30, 2021 | 83.02% |
| May 31, 2021 | 83.02% |
| April 30, 2021 | 82.46% |
| March 31, 2021 | 80.49% |
| February 28, 2021 | 77.61% |
| January 31, 2021 | 77.50% |
| December 31, 2020 | 77.50% |
| November 30, 2020 | 77.50% |
| October 31, 2020 | 74.40% |
| September 30, 2020 | 74.40% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
74.40%
Minimum
Nov 2019
99.30%
Maximum
Oct 2024
86.53%
Average
84.43%
Median
Max Drawdown (5Y) Benchmarks
| Imunon Inc | 99.38% |
| Cormedix Inc | 93.38% |
| Aethlon Medical Inc | 99.76% |
| Outlook Therapeutics Inc | 98.82% |
| Aprea Therapeutics Inc | 99.74% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -56.59 |
| Beta (5Y) | 0.4012 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 113.5% |
| Historical Sharpe Ratio (5Y) | -0.4532 |
| Historical Sortino (5Y) | -0.7735 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 50.42% |